Prevalence of ESBLs and Integrons in Clinical Isolates of Salmonella spp. From Four Hospitals of Tehran | Zendy

Kobra Salimian Rizi | Zendy; Shahin Najar Peerayeh | Zendy; Bita Bakhshi | Zendy; Mohammad Rahbar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prevalence of ESBLs and Integrons in Clinical Isolates of Salmonella spp. From Four Hospitals of Tehran

Author(s) -

Kobra Salimian Rizi,

Shahin Najar Peerayeh,

Bita Bakhshi,

Mohammad Rahbar

Publication year - 2015

Publication title -

international journal of enteric pathogens

Language(s) - English

Resource type - Journals

eISSN - 2345-3362

pISSN - 2322-5866

DOI - 10.17795/ijep21820

Subject(s) - integron , salmonella , nalidixic acid , microbiology and biotechnology , imipenem , biology , ciprofloxacin , multiple drug resistance , trimethoprim , antibiotic resistance , drug resistance , virology , antibiotics , genetics , bacteria

genes. Results: Maximal resistance in Salmonella isolates was noticed against trimethoprim–sulfamethoxazole (63/6%) and nalidixic-acid (47/3%). All of isolates were susceptible to imipenem and ciprofloxacin. Four (3.6%) isolates showed ESBLs phenotype. Thirty six of Salmonella isolates have integron but there was not detected class 3 of integrons among isolates. Conclusions: The present study shows the high prevalence of MDR among Salmonella isolates and so alarms the importance of continued monitoring of drug resistance in clinical settings.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research